Covid shots designed to protect against the omicron variant trigger a weaker immune response against the rapidly emerging BQ.1.1 subvariant than the previously dominant strain, according to a new lab study.
A study yesterday in JAMA Internal Medicine shows women and racial minorities were underrepresented in both COVID-19 clinical treatment trials and in disease prevention trials.
The research was conducted by a team from the Fred Hutchinson Cancer Center, as well researchers from Beijing and London.
Vaccine hesitancy about COVID-19 vaccines is a positive predictor of negative side effects with vaccination—an example of the "nocebo" effect—according to a study today in Scientific Reports.
Nocebo, a play on placebo, is a phenomenon in which people experience negative effects on health when they have negative views or expectations surrounding medical interventions.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/7LY2VV7YGBNE5AEH4WRN2FIOGU.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/6EF6LNO5WJLR7MCFLP3PIXS3UU.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/TP5R6HBNPZIGTOANNA35PFUUUM.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/JMHPCPSAUZI3FHB76L5ERKRFNE.jpg)
Recent Comments